title: [Side effects during treatment with Solu-Medrol for optic neuritis in the course of MS].
abstract: The aim of this research is, to show the action mechanism of metyloprednizolon and the side--effects of the Solu-Medrol application in the treatment of demyelinization neuritis of ophtalmic nerve in sclerosis multiplex. In research, there were described the side-effects after second Solu-Medrol bolus dose given to a 44-year-old patient. She has suffered from SM and demyelinization neuritis of ophtalmic nerve with rapid deterioration of visual acuity for 14 years. In the years 1995-2002 there has not been any case of side-effects similar to this patient's, among all the 30 other patients treated with Solu-Medrol. It confirms the usefulness of bolus dose metyloprednizolon therapy applied to patients suffering from ophtalmic nerve demyelinization with rapid deterioration of visual acuity.
authors.affiliation: Oddziału Okulistycznego Wojewódzkiego Szpitala Specjalistycznego nr 3 w Rybniku.
authors.forename: Lidia
authors.initials: L
authors.lastname: Mazur-Chłodek
authors.forename: Aniela
authors.initials: A
authors.lastname: Kaliciak-Kempińska
mesh_terms: D000328:Adult; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007960:Leukocyte Disorders / Q000139:chemically induced; D008776:Methylprednisolone Hemisuccinate / Q000008:administration & dosage / Q000009:adverse effects*; D009103:Multiple Sclerosis / Q000150:complications*; D009325:Nausea / Q000139:chemically induced; D018696:Neuroprotective Agents / Q000009:adverse effects*; D009902:Optic Neuritis / Q000150:complications* / Q000188:drug therapy*
chemical_list: D018696:Neuroprotective Agents; D008776:Methylprednisolone Hemisuccinate